ODQ
(HB2900)- Data
- Support & Resources
Data
Product overview
-
Name
ODQ
-
Short description
Potent, selective guanylyl cyclase inhibitor
-
Biological description
Potent, selective guanylyl cyclase inhibitor (IC50 = ~20 nM). Shows anxiolytic and anti-tumour actions. Also shows potential memory disturbing effects.
-
Purity
>98%
- Citations
Properties
-
Chemical name
1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one
-
Molecular Weight
187.16
-
Chemical structure
-
Molecular Formula
C9H5N3O2
-
CAS Number
41443-28-1
-
PubChem identifier
1456
-
SMILES
C1=CC=C2C(=C1)N=CC3=NOC(=O)N23
-
Source
Synthetic
-
InChi
InChI=1S/C9H5N3O2/c13-9-12-7-4-2-1-3-6(7)10-5-8(12)11-14-9/h1-5H
-
InChiKey
LZMHWZHOZLVYDL-UHFFFAOYSA-N
-
MDL number
MFCD00792620
-
Appearance
White solid
Storing and Using Your Product
-
Storage instructions
+4°C
-
Solubility overview
Soluble in DMSO (100mM) and in ethanol (20 mM, gentle warming)
-
Important
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.
References for ODQ
-
Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase.
Boulton et al (1995) Neuroscienec 69(3) : 699-703PubMedID: 8596640 -
In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
Fedele et al (1996) Br J Pharmacol 119(3) : 590-4PubMedID: 8894183 -
Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
Garthwaite et al (1995) Moll Pharmacol 48(2) : 184-8PubMedID: 7544433
Support & Resources